Presentation by Rick Prinzen, Chief Supply Chain Officer, Canadian Blood Services.

In this presentation, the Canadian Blood Service Distinctive Distribution Network is examined.

• Understand more about their organizational structure and how their unique supply chain operates
  
• Review the constraints and considerations for shipping blood everyday with small parcel shipments across the country
  
• How to navigate through blood products’ challenging time constraints, outdate considerations, temp control needs and emergency shipments
  
• Ensure the national inventory is balanced through ramped up collections to avoid shortages
• Discuss the complexities around shipping blood to remote and far north regions
  

Presentation by Navid Choudhury, Senior Manager, Supply Chain Planning, Novo Nordisk.

BEST PRACTICE SHARING: Learn about BPOG’s Collaborative Best- Practice Strategy for Temperature Controlled Transportation Validation.

• Discover what 14 pharmaceutical global companies involved in the working group have collaboratively determined to be the best-practice strategies for shipping lane and equipment validation
• Uncover potential solutions to your transportation challenges with an informative presentation featuring the expertise and experience of 14 big and small pharma manufacturers
• Benchmark your current strategies with the collective strategies of all the involved parties
  

Check out our end of the day keynote by Merrick Rosenberg, CEO and Co-founder, Take Flight Learning, Author The Chameleon.

• Discover the four personality styles and how they affect the way you interact with others
• Gain the ability to quickly and accurately read people’s styles in any setting
• Understand how overusing your strengths creates weaknesses
• Learn how to intuit the intent behind people’s behavior
  

Presentation by Julie Carriere, VP Quality Assurance & Regulatory Affairs, Accuristix, a division of ATS

Canada offers challenges to temperature controlled shipments, from the size and breadth of the country to the wide range of temperatures throughout the year. 3PLs distributing across Canada for their clients face unique challenges of complexity that seem difficult to tame. In this presentation:

• Review the benefits to shippers of reusable pack-outs based on their experience as a high volume shipper
• Analyze the unique benefits within a multi-client (3PL) environment of having a universal pack-out
  
  

See results from Eli Lily's biologic shipping study launch exploring how they sent 5 different biologic products on the ocean:

• How they dealt with the different dynamics of launching from both Europe & US at the same time
• Discuss their expansion to different countries on the current platform
• Review the qualification & regulatory requirements for shipping biologics- change control process of each country
• How to deal with different expectations around the data temperature profiles for biologics
  

Presentation by Jill Craven, VP Pharmacy Services, Mohawk Medbuy Corporation.

• Discuss the group buying organization structure and how back orders can cause severe delays
• Review the impact outsourced materials from India & China have on shortages in Canada
• How to prepare for shortages ahead of time by adjusting your inventory management & demand planning
• What are the impacts to the rest of the supply chain if corners are cut to lower costs? And the patient?
• Why are we seeing more shortages now than we ever have before?
  

Though life sciences companies see value across the full supply chain, it’s the last mile that matters the most to the customer. With this in mind, we surveyed 150+ pharma logistics leaders to learn more about the key challenges, solutions and trends impacting the last mile of the life sciences supply chain.

Highlights include:

• Analysis of what causes the most last mile disruptions and how firms are addressing these issues
• An overview of our respondents top strategic priorities
• Facts & figures that outline where cold chain leaders are looking to invest in 2018 & 2019
  

To be adequately equipped to distribute medicines throughout Canada, pharma firms must be fully educated on the bespoke pain points this region has to offer. Canada’s pharmaceutical market is primed to grow to $25 bn by 2021, according to consulting firm GlobalData. With a 2.5% share of the global market, Canada stands as the 10th largest pharma market. However, Canada has unique complications and hurdles, which greatly complicate the task of distributing temperature sensitive medicines within the region. 

In this in-depth whitepaper, we explore the challenges and opportunities associated with achieving temperature supply chain excellence in Canada such as:

• Vast Territories 
• Extreme Temperatures
• Validated Cold Chain Systems 
• Outsourcing and Collaboration 
• & more
  

Strategic and effective supply chain planning and management can help improve processes, increase cost efficiency and provide a robust, secure end-to-end journey for products. But maintaining GDP compliance whilst ensuring cost efficiency throughout the supply chain can often be challenging; selecting the right partners and solutions, and managing them effectively, is critical in order to avoid unnecessary expenditure from the planning stages right through to the last mile.

We wanted to build an understanding of the areas of the supply chain where the TCL market is overspending, and examine how these areas could be improved to increase cost-effectiveness. This report will analyze the most important considerations when selecting supply chain partners, taking into account the importance of price compared to other elements such as technology and level of service. It will also look into the current barriers to reducing supply chain costs and the new technologies that have the potential to uncover efficiencies in supply chain management.

Experts forecast that 2018 can expect cyber breaches only to get bigger with hackers and technologies getting smarter. This reality forces all organizations to bolster their defences – some are turning to machine-learning based features to automate risk detection by filtering alert data.

Alongside utilising the benefits of digitalization, such as IoT enabled manufacturing and cloud systems, the industry must too understand the cyber security vulnerabilities and respond with the needed precautions. The sensitive data housed by healthcare, pharmaceutical and biotech firms are key targets for hackers. GDPR regulators are predicted to make an example of firms which do not take safeguarding data subjects seriously.

Hit download to continue reading......

Maintaining a high standard of GDP logistics compliance is a difficult task. By following these seven steps, you can:

• understand the standard expected of you,
  
• document how you are meeting and maintaining these standards,
• be prepared to answer questions from inspectors, and,
• take a snapshot view of your performance.

A typical excursion can take over 40 labor hours to investigate involving multiple departments. Reducing that time by even just 10% per investigation through better collaboration efforts can save hundreds of thousands of dollars for an organization.

Due to the implications of improperly stored drugs, regulator demands have become more stringent and pharmaceutical companies need to be able to prove that their products are not compromised by temperature excursions.

Facing a potential excursion, manufacturers must be able to verify the product status to prevent risking patient safety, but also avoid incurring any unnecessary wastage.

In this report, Pharma IQ spoke exclusively to Saddam Huq, Global QA Senior Manager, Distribution & Cold Chain, GSK Vaccines about temperature excursions on a global scale and managing the risks associated with different regions, freight types and the challenges of data management.

As 2019 CCGF Canada speaker Nedal Ismail, Professor and Program Coordinator Bachelor of Commerce, Supply Chain Management & Management Studies, The Business School, Humber Institute of Technology & Advanced Learning, puts it, though "it is not immediately apparent if blockchain will bring an incremental change (i.e. a marginal improvement in existing processes), or a disruptive change (one that will completely change the way the business is conducted), one thing is clear: blockchain stands to transform pharma logistics over the next decade. From enabling increased transparency, security, communication and efficiency, the potential benefits of blockchain seem limitless.

In this in-depth report, we demystify blockchain by shedding light on:

• Current use cases and applications of blockchain in pharma logistics both here in Canada and abroad
• Key barriers to adoption and challenges associated with blockchain
• The future of blockchain technology and how it could potentially be used to optimize the pharma supply chain in years to come
• Why Canada is becoming a global hub for blockchain innovation both within life sciences and beyond

This whitepapers covers the latest pharmaceutical logistics regulatory developments around the globe related to FMD, MHRA, ICH Q12, PACMP, GMP, DSCSA and more! Designed specifically to keep you up to date with key developments that will shape the compliance agenda. Highlights include:

• GMP inspections international collaboration efforts
• Supply Chain Security and Traceability – GPS
• EMA regulations
• Points to remember for your next GDP inspection
• The latest on Human Drug Compounding Outsourcing Facilities regulations
• An analysis of ICH Q12 concepts
• The cost of Brexit and the road forward
• An overview of EU's recently published report detailing the implementation of the Falsified Medicines Directive (FMD)
  

IQPC is pleased to announce the new Keynote speaker for the 17th Cold Chain Global Forum Canada! Joining the all-star speaker faculty alongside Canadian Blood Services, Sandoz Canada, and Roche Diagnostics is Kimby Barton, Director of the Health Product and Licensing Division (HPIL), Health Products Compliance Directorate at Health Canada’s Regulatory Operation and Regions Branch.

View the press release to learn more about Kimby Barton and her Keynote session.

Have you heard the buzz? Cold Chain Global Forum CANADA is back! While we're hard at work developing our 2019 program, check out our 2018 Post Show Report to find out what you missed last time around. This short event recap includes:

• Facts & figures from our onsite survey of 100+ supply chain leaders covering Canadian-specific challenges, strategic priorities and new trends for the year to come
• Who attended and what they learned
  
• A sneak peek of what we have planned for the 2019 Cold Chain Global Forun CANADA 

Find out why Cold Chain Global Forum CANADA is the most trusted temperature control supply chain industry event and start building your business case to join us at the next GF Canada taking place February 25-28, 2019 in Toronto, ON.